nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—PTGS2—atherosclerosis	0.49	1	CbGaD
Triamcinolone—CYP3A4—Rosuvastatin—atherosclerosis	0.0332	0.211	CbGbCtD
Triamcinolone—CYP3A4—Ezetimibe—atherosclerosis	0.0332	0.211	CbGbCtD
Triamcinolone—CYP3A4—Simvastatin—atherosclerosis	0.0308	0.196	CbGbCtD
Triamcinolone—CYP3A4—Lovastatin—atherosclerosis	0.0302	0.192	CbGbCtD
Triamcinolone—CYP3A4—Pravastatin—atherosclerosis	0.0302	0.192	CbGbCtD
Triamcinolone—Myopathy—Ezetimibe—atherosclerosis	0.00246	0.011	CcSEcCtD
Triamcinolone—Myopathy—Simvastatin—atherosclerosis	0.00234	0.0105	CcSEcCtD
Triamcinolone—Cough increased—Rosuvastatin—atherosclerosis	0.00226	0.0101	CcSEcCtD
Triamcinolone—Peptic ulcer—Niacin—atherosclerosis	0.00226	0.0101	CcSEcCtD
Triamcinolone—Myopathy—Niacin—atherosclerosis	0.00215	0.00961	CcSEcCtD
Triamcinolone—Hepatomegaly—Niacin—atherosclerosis	0.00213	0.00952	CcSEcCtD
Triamcinolone—Myopathy—Pravastatin—atherosclerosis	0.00212	0.00946	CcSEcCtD
Triamcinolone—Glaucoma—Niacin—atherosclerosis	0.002	0.00895	CcSEcCtD
Triamcinolone—Cataract—Lovastatin—atherosclerosis	0.00185	0.00825	CcSEcCtD
Triamcinolone—Vasculitis—Lovastatin—atherosclerosis	0.0018	0.00804	CcSEcCtD
Triamcinolone—Vasculitis—Ezetimibe—atherosclerosis	0.00177	0.00789	CcSEcCtD
Triamcinolone—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.00173	0.00773	CcSEcCtD
Triamcinolone—Cataract—Simvastatin—atherosclerosis	0.00173	0.00771	CcSEcCtD
Triamcinolone—Vasculitis—Simvastatin—atherosclerosis	0.00168	0.00752	CcSEcCtD
Triamcinolone—Cough increased—Niacin—atherosclerosis	0.00165	0.00736	CcSEcCtD
Triamcinolone—Injury—Rosuvastatin—atherosclerosis	0.00164	0.00731	CcSEcCtD
Triamcinolone—Cataract—Pravastatin—atherosclerosis	0.00156	0.00697	CcSEcCtD
Triamcinolone—Vasculitis—Pravastatin—atherosclerosis	0.00152	0.0068	CcSEcCtD
Triamcinolone—Dermatitis contact—Niacin—atherosclerosis	0.00149	0.00666	CcSEcCtD
Triamcinolone—PTGS2—leg—atherosclerosis	0.00148	0.151	CbGeAlD
Triamcinolone—Skin exfoliation—Niacin—atherosclerosis	0.00144	0.00644	CcSEcCtD
Triamcinolone—Betamethasone—PLA2G1B—atherosclerosis	0.00143	0.4	CrCbGaD
Triamcinolone—Fluid retention—Niacin—atherosclerosis	0.00143	0.0064	CcSEcCtD
Triamcinolone—Vascular purpura—Lovastatin—atherosclerosis	0.00143	0.00637	CcSEcCtD
Triamcinolone—Neuropathy—Pravastatin—atherosclerosis	0.00139	0.00623	CcSEcCtD
Triamcinolone—Injury—Lovastatin—atherosclerosis	0.00139	0.0062	CcSEcCtD
Triamcinolone—Diabetes mellitus—Simvastatin—atherosclerosis	0.00137	0.00613	CcSEcCtD
Triamcinolone—Vascular purpura—Simvastatin—atherosclerosis	0.00133	0.00596	CcSEcCtD
Triamcinolone—Muscular weakness—Rosuvastatin—atherosclerosis	0.00133	0.00593	CcSEcCtD
Triamcinolone—PTGS2—hindlimb—atherosclerosis	0.00133	0.135	CbGeAlD
Triamcinolone—Purpura—Lovastatin—atherosclerosis	0.00132	0.00591	CcSEcCtD
Triamcinolone—Influenza—Rosuvastatin—atherosclerosis	0.0013	0.00581	CcSEcCtD
Triamcinolone—Pancreatitis—Rosuvastatin—atherosclerosis	0.00127	0.0057	CcSEcCtD
Triamcinolone—Diabetes mellitus—Niacin—atherosclerosis	0.00126	0.00563	CcSEcCtD
Triamcinolone—Bronchitis—Rosuvastatin—atherosclerosis	0.00125	0.00559	CcSEcCtD
Triamcinolone—Purpura—Simvastatin—atherosclerosis	0.00124	0.00553	CcSEcCtD
Triamcinolone—Vascular purpura—Pravastatin—atherosclerosis	0.00121	0.00539	CcSEcCtD
Triamcinolone—Injury—Pravastatin—atherosclerosis	0.00117	0.00524	CcSEcCtD
Triamcinolone—Dermatitis bullous—Niacin—atherosclerosis	0.00115	0.00512	CcSEcCtD
Triamcinolone—PTGS2—appendage—atherosclerosis	0.00114	0.116	CbGeAlD
Triamcinolone—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00114	0.00508	CcSEcCtD
Triamcinolone—Purpura—Pravastatin—atherosclerosis	0.00112	0.005	CcSEcCtD
Triamcinolone—Muscular weakness—Ezetimibe—atherosclerosis	0.0011	0.00493	CcSEcCtD
Triamcinolone—Influenza—Lovastatin—atherosclerosis	0.0011	0.00492	CcSEcCtD
Triamcinolone—Influenza—Ezetimibe—atherosclerosis	0.00108	0.00483	CcSEcCtD
Triamcinolone—Pancreatitis—Lovastatin—atherosclerosis	0.00108	0.00483	CcSEcCtD
Triamcinolone—Affect lability—Pravastatin—atherosclerosis	0.00106	0.00474	CcSEcCtD
Triamcinolone—Pancreatitis—Ezetimibe—atherosclerosis	0.00106	0.00474	CcSEcCtD
Triamcinolone—Muscular weakness—Simvastatin—atherosclerosis	0.00105	0.0047	CcSEcCtD
Triamcinolone—Rhinitis—Rosuvastatin—atherosclerosis	0.00104	0.00466	CcSEcCtD
Triamcinolone—Pharyngitis—Rosuvastatin—atherosclerosis	0.00103	0.00462	CcSEcCtD
Triamcinolone—Mood swings—Pravastatin—atherosclerosis	0.00102	0.00456	CcSEcCtD
Triamcinolone—Pancreatitis—Simvastatin—atherosclerosis	0.00101	0.00452	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.001	0.00449	CcSEcCtD
Triamcinolone—Bronchitis—Simvastatin—atherosclerosis	0.000991	0.00443	CcSEcCtD
Triamcinolone—Muscular weakness—Niacin—atherosclerosis	0.000966	0.00432	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000963	0.0043	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000958	0.00428	CcSEcCtD
Triamcinolone—Abdominal distension—Niacin—atherosclerosis	0.000953	0.00426	CcSEcCtD
Triamcinolone—Muscular weakness—Pravastatin—atherosclerosis	0.000951	0.00425	CcSEcCtD
Triamcinolone—Influenza—Niacin—atherosclerosis	0.000946	0.00423	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000945	0.00422	CcSEcCtD
Triamcinolone—Abdominal distension—Pravastatin—atherosclerosis	0.000938	0.00419	CcSEcCtD
Triamcinolone—Influenza—Pravastatin—atherosclerosis	0.000932	0.00416	CcSEcCtD
Triamcinolone—Arrhythmia—Rosuvastatin—atherosclerosis	0.00093	0.00416	CcSEcCtD
Triamcinolone—Pancreatitis—Pravastatin—atherosclerosis	0.000914	0.00408	CcSEcCtD
Triamcinolone—Bronchitis—Niacin—atherosclerosis	0.00091	0.00407	CcSEcCtD
Triamcinolone—Sweating increased—Pravastatin—atherosclerosis	0.000908	0.00406	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000901	0.00403	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000866	0.00387	CcSEcCtD
Triamcinolone—Pharyngitis—Ezetimibe—atherosclerosis	0.000859	0.00384	CcSEcCtD
Triamcinolone—Weight increased—Pravastatin—atherosclerosis	0.000848	0.00379	CcSEcCtD
Triamcinolone—Dexamethasone—PLA2G1B—atherosclerosis	0.000834	0.233	CrCbGaD
Triamcinolone—Angioedema—Rosuvastatin—atherosclerosis	0.000828	0.0037	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000819	0.00366	CcSEcCtD
Triamcinolone—Myocardial infarction—Pravastatin—atherosclerosis	0.000814	0.00364	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000814	0.00364	CcSEcCtD
Triamcinolone—PTGS2—artery—atherosclerosis	0.000812	0.0826	CbGeAlD
Triamcinolone—Cough—Rosuvastatin—atherosclerosis	0.000791	0.00353	CcSEcCtD
Triamcinolone—Myalgia—Rosuvastatin—atherosclerosis	0.000771	0.00345	CcSEcCtD
Triamcinolone—Haemoglobin—Niacin—atherosclerosis	0.000761	0.0034	CcSEcCtD
Triamcinolone—Rhinitis—Niacin—atherosclerosis	0.000759	0.00339	CcSEcCtD
Triamcinolone—Haemorrhage—Niacin—atherosclerosis	0.000758	0.00339	CcSEcCtD
Triamcinolone—Erythema—Ezetimibe—atherosclerosis	0.000753	0.00337	CcSEcCtD
Triamcinolone—Dysgeusia—Lovastatin—atherosclerosis	0.000752	0.00336	CcSEcCtD
Triamcinolone—Rhinitis—Pravastatin—atherosclerosis	0.000748	0.00334	CcSEcCtD
Triamcinolone—Back pain—Lovastatin—atherosclerosis	0.000743	0.00332	CcSEcCtD
Triamcinolone—Pharyngitis—Pravastatin—atherosclerosis	0.00074	0.00331	CcSEcCtD
Triamcinolone—Infection—Rosuvastatin—atherosclerosis	0.000735	0.00328	CcSEcCtD
Triamcinolone—Back pain—Ezetimibe—atherosclerosis	0.000728	0.00326	CcSEcCtD
Triamcinolone—Erythema—Simvastatin—atherosclerosis	0.000718	0.00321	CcSEcCtD
Triamcinolone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000712	0.00318	CcSEcCtD
Triamcinolone—Dysgeusia—Simvastatin—atherosclerosis	0.000703	0.00314	CcSEcCtD
Triamcinolone—Angioedema—Lovastatin—atherosclerosis	0.000702	0.00314	CcSEcCtD
Triamcinolone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000699	0.00312	CcSEcCtD
Triamcinolone—Malaise—Lovastatin—atherosclerosis	0.000692	0.00309	CcSEcCtD
Triamcinolone—Vertigo—Lovastatin—atherosclerosis	0.00069	0.00308	CcSEcCtD
Triamcinolone—Angioedema—Ezetimibe—atherosclerosis	0.000688	0.00308	CcSEcCtD
Triamcinolone—PTGS2—endothelium—atherosclerosis	0.000686	0.0698	CbGeAlD
Triamcinolone—Malaise—Ezetimibe—atherosclerosis	0.000679	0.00303	CcSEcCtD
Triamcinolone—Arrhythmia—Niacin—atherosclerosis	0.000677	0.00302	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000674	0.00301	CcSEcCtD
Triamcinolone—Insomnia—Rosuvastatin—atherosclerosis	0.000669	0.00299	CcSEcCtD
Triamcinolone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000666	0.00298	CcSEcCtD
Triamcinolone—Arrhythmia—Pravastatin—atherosclerosis	0.000666	0.00298	CcSEcCtD
Triamcinolone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000664	0.00297	CcSEcCtD
Triamcinolone—Erythema—Niacin—atherosclerosis	0.000659	0.00295	CcSEcCtD
Triamcinolone—Cough—Ezetimibe—atherosclerosis	0.000657	0.00294	CcSEcCtD
Triamcinolone—Angioedema—Simvastatin—atherosclerosis	0.000656	0.00293	CcSEcCtD
Triamcinolone—Myalgia—Lovastatin—atherosclerosis	0.000654	0.00292	CcSEcCtD
Triamcinolone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000651	0.00291	CcSEcCtD
Triamcinolone—Hypertension—Ezetimibe—atherosclerosis	0.00065	0.00291	CcSEcCtD
Triamcinolone—Malaise—Simvastatin—atherosclerosis	0.000648	0.00289	CcSEcCtD
Triamcinolone—Discomfort—Lovastatin—atherosclerosis	0.000646	0.00289	CcSEcCtD
Triamcinolone—Vertigo—Simvastatin—atherosclerosis	0.000645	0.00288	CcSEcCtD
Triamcinolone—Myalgia—Ezetimibe—atherosclerosis	0.000641	0.00287	CcSEcCtD
Triamcinolone—Dry mouth—Lovastatin—atherosclerosis	0.000639	0.00286	CcSEcCtD
Triamcinolone—Dysgeusia—Pravastatin—atherosclerosis	0.000636	0.00284	CcSEcCtD
Triamcinolone—Discomfort—Ezetimibe—atherosclerosis	0.000633	0.00283	CcSEcCtD
Triamcinolone—PTGS2—blood vessel—atherosclerosis	0.000633	0.0644	CbGeAlD
Triamcinolone—Pain—Rosuvastatin—atherosclerosis	0.000632	0.00283	CcSEcCtD
Triamcinolone—Dry mouth—Ezetimibe—atherosclerosis	0.000627	0.0028	CcSEcCtD
Triamcinolone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000627	0.0028	CcSEcCtD
Triamcinolone—Infection—Lovastatin—atherosclerosis	0.000623	0.00278	CcSEcCtD
Triamcinolone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000615	0.00275	CcSEcCtD
Triamcinolone—Myalgia—Simvastatin—atherosclerosis	0.000611	0.00273	CcSEcCtD
Triamcinolone—Infection—Ezetimibe—atherosclerosis	0.000611	0.00273	CcSEcCtD
Triamcinolone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000609	0.00272	CcSEcCtD
Triamcinolone—Discomfort—Simvastatin—atherosclerosis	0.000604	0.0027	CcSEcCtD
Triamcinolone—Angioedema—Niacin—atherosclerosis	0.000603	0.00269	CcSEcCtD
Triamcinolone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000602	0.00269	CcSEcCtD
Triamcinolone—Angioedema—Pravastatin—atherosclerosis	0.000593	0.00265	CcSEcCtD
Triamcinolone—Vertigo—Niacin—atherosclerosis	0.000592	0.00265	CcSEcCtD
Triamcinolone—Syncope—Niacin—atherosclerosis	0.000591	0.00264	CcSEcCtD
Triamcinolone—Urticaria—Rosuvastatin—atherosclerosis	0.000587	0.00263	CcSEcCtD
Triamcinolone—Oedema—Simvastatin—atherosclerosis	0.000586	0.00262	CcSEcCtD
Triamcinolone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000586	0.00262	CcSEcCtD
Triamcinolone—Malaise—Pravastatin—atherosclerosis	0.000586	0.00262	CcSEcCtD
Triamcinolone—Vertigo—Pravastatin—atherosclerosis	0.000583	0.00261	CcSEcCtD
Triamcinolone—Infection—Simvastatin—atherosclerosis	0.000582	0.0026	CcSEcCtD
Triamcinolone—Loss of consciousness—Niacin—atherosclerosis	0.00058	0.00259	CcSEcCtD
Triamcinolone—Cough—Niacin—atherosclerosis	0.000575	0.00257	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000571	0.00255	CcSEcCtD
Triamcinolone—Insomnia—Lovastatin—atherosclerosis	0.000567	0.00253	CcSEcCtD
Triamcinolone—Cough—Pravastatin—atherosclerosis	0.000567	0.00253	CcSEcCtD
Triamcinolone—Paraesthesia—Lovastatin—atherosclerosis	0.000563	0.00251	CcSEcCtD
Triamcinolone—Myalgia—Niacin—atherosclerosis	0.000561	0.00251	CcSEcCtD
Triamcinolone—Hypertension—Pravastatin—atherosclerosis	0.000561	0.00251	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00056	0.0025	CcSEcCtD
Triamcinolone—Dyspnoea—Lovastatin—atherosclerosis	0.000559	0.0025	CcSEcCtD
Triamcinolone—Insomnia—Ezetimibe—atherosclerosis	0.000556	0.00248	CcSEcCtD
Triamcinolone—Myalgia—Pravastatin—atherosclerosis	0.000553	0.00247	CcSEcCtD
Triamcinolone—Paraesthesia—Ezetimibe—atherosclerosis	0.000552	0.00247	CcSEcCtD
Triamcinolone—Dyspepsia—Lovastatin—atherosclerosis	0.000552	0.00247	CcSEcCtD
Triamcinolone—Dry mouth—Niacin—atherosclerosis	0.000549	0.00245	CcSEcCtD
Triamcinolone—Dyspnoea—Ezetimibe—atherosclerosis	0.000548	0.00245	CcSEcCtD
Triamcinolone—Discomfort—Pravastatin—atherosclerosis	0.000546	0.00244	CcSEcCtD
Triamcinolone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000545	0.00243	CcSEcCtD
Triamcinolone—Dyspepsia—Ezetimibe—atherosclerosis	0.000541	0.00242	CcSEcCtD
Triamcinolone—Fatigue—Lovastatin—atherosclerosis	0.00054	0.00241	CcSEcCtD
Triamcinolone—Anaphylactic shock—Niacin—atherosclerosis	0.000538	0.00241	CcSEcCtD
Triamcinolone—Oedema—Niacin—atherosclerosis	0.000538	0.00241	CcSEcCtD
Triamcinolone—Pain—Lovastatin—atherosclerosis	0.000536	0.00239	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000534	0.00239	CcSEcCtD
Triamcinolone—Asthenia—Rosuvastatin—atherosclerosis	0.000531	0.00237	CcSEcCtD
Triamcinolone—Insomnia—Simvastatin—atherosclerosis	0.00053	0.00237	CcSEcCtD
Triamcinolone—Oedema—Pravastatin—atherosclerosis	0.00053	0.00237	CcSEcCtD
Triamcinolone—Anaphylactic shock—Pravastatin—atherosclerosis	0.00053	0.00237	CcSEcCtD
Triamcinolone—Fatigue—Ezetimibe—atherosclerosis	0.00053	0.00237	CcSEcCtD
Triamcinolone—Shock—Niacin—atherosclerosis	0.000529	0.00237	CcSEcCtD
Triamcinolone—Infection—Pravastatin—atherosclerosis	0.000526	0.00235	CcSEcCtD
Triamcinolone—Paraesthesia—Simvastatin—atherosclerosis	0.000526	0.00235	CcSEcCtD
Triamcinolone—Pain—Ezetimibe—atherosclerosis	0.000526	0.00235	CcSEcCtD
Triamcinolone—Tachycardia—Niacin—atherosclerosis	0.000525	0.00235	CcSEcCtD
Triamcinolone—Pruritus—Rosuvastatin—atherosclerosis	0.000523	0.00234	CcSEcCtD
Triamcinolone—Dyspnoea—Simvastatin—atherosclerosis	0.000523	0.00234	CcSEcCtD
Triamcinolone—Hyperhidrosis—Niacin—atherosclerosis	0.00052	0.00233	CcSEcCtD
Triamcinolone—Feeling abnormal—Lovastatin—atherosclerosis	0.000516	0.00231	CcSEcCtD
Triamcinolone—Dyspepsia—Simvastatin—atherosclerosis	0.000516	0.00231	CcSEcCtD
Triamcinolone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000512	0.00229	CcSEcCtD
Triamcinolone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000506	0.00226	CcSEcCtD
Triamcinolone—Fatigue—Simvastatin—atherosclerosis	0.000505	0.00226	CcSEcCtD
Triamcinolone—Pain—Simvastatin—atherosclerosis	0.000501	0.00224	CcSEcCtD
Triamcinolone—Urticaria—Lovastatin—atherosclerosis	0.000498	0.00222	CcSEcCtD
Triamcinolone—Body temperature increased—Lovastatin—atherosclerosis	0.000495	0.00221	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00049	0.00219	CcSEcCtD
Triamcinolone—Dizziness—Rosuvastatin—atherosclerosis	0.000489	0.00219	CcSEcCtD
Triamcinolone—Urticaria—Ezetimibe—atherosclerosis	0.000488	0.00218	CcSEcCtD
Triamcinolone—Insomnia—Niacin—atherosclerosis	0.000487	0.00218	CcSEcCtD
Triamcinolone—Body temperature increased—Ezetimibe—atherosclerosis	0.000486	0.00217	CcSEcCtD
Triamcinolone—Paraesthesia—Niacin—atherosclerosis	0.000483	0.00216	CcSEcCtD
Triamcinolone—Feeling abnormal—Simvastatin—atherosclerosis	0.000483	0.00216	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000483	0.00216	CcSEcCtD
Triamcinolone—Dyspnoea—Niacin—atherosclerosis	0.00048	0.00214	CcSEcCtD
Triamcinolone—Insomnia—Pravastatin—atherosclerosis	0.000479	0.00214	CcSEcCtD
Triamcinolone—Paraesthesia—Pravastatin—atherosclerosis	0.000476	0.00213	CcSEcCtD
Triamcinolone—Dyspepsia—Niacin—atherosclerosis	0.000474	0.00212	CcSEcCtD
Triamcinolone—Dyspnoea—Pravastatin—atherosclerosis	0.000472	0.00211	CcSEcCtD
Triamcinolone—Fluoxymesterone—ESR1—atherosclerosis	0.000472	0.132	CrCbGaD
Triamcinolone—Dyspepsia—Pravastatin—atherosclerosis	0.000466	0.00208	CcSEcCtD
Triamcinolone—Rash—Rosuvastatin—atherosclerosis	0.000466	0.00208	CcSEcCtD
Triamcinolone—Dermatitis—Rosuvastatin—atherosclerosis	0.000466	0.00208	CcSEcCtD
Triamcinolone—Urticaria—Simvastatin—atherosclerosis	0.000466	0.00208	CcSEcCtD
Triamcinolone—Body temperature increased—Simvastatin—atherosclerosis	0.000463	0.00207	CcSEcCtD
Triamcinolone—Headache—Rosuvastatin—atherosclerosis	0.000463	0.00207	CcSEcCtD
Triamcinolone—Hypersensitivity—Lovastatin—atherosclerosis	0.000462	0.00206	CcSEcCtD
Triamcinolone—SERPINA6—liver—atherosclerosis	0.000461	0.0469	CbGeAlD
Triamcinolone—Pain—Niacin—atherosclerosis	0.00046	0.00206	CcSEcCtD
Triamcinolone—Fatigue—Pravastatin—atherosclerosis	0.000457	0.00204	CcSEcCtD
Triamcinolone—Pain—Pravastatin—atherosclerosis	0.000453	0.00203	CcSEcCtD
Triamcinolone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000453	0.00202	CcSEcCtD
Triamcinolone—Asthenia—Lovastatin—atherosclerosis	0.00045	0.00201	CcSEcCtD
Triamcinolone—Pruritus—Lovastatin—atherosclerosis	0.000443	0.00198	CcSEcCtD
Triamcinolone—Asthenia—Ezetimibe—atherosclerosis	0.000441	0.00197	CcSEcCtD
Triamcinolone—Nausea—Rosuvastatin—atherosclerosis	0.000439	0.00196	CcSEcCtD
Triamcinolone—Feeling abnormal—Pravastatin—atherosclerosis	0.000437	0.00195	CcSEcCtD
Triamcinolone—Pruritus—Ezetimibe—atherosclerosis	0.000435	0.00194	CcSEcCtD
Triamcinolone—Hypersensitivity—Simvastatin—atherosclerosis	0.000432	0.00193	CcSEcCtD
Triamcinolone—Urticaria—Niacin—atherosclerosis	0.000428	0.00191	CcSEcCtD
Triamcinolone—Body temperature increased—Niacin—atherosclerosis	0.000425	0.0019	CcSEcCtD
Triamcinolone—Urticaria—Pravastatin—atherosclerosis	0.000421	0.00188	CcSEcCtD
Triamcinolone—Asthenia—Simvastatin—atherosclerosis	0.000421	0.00188	CcSEcCtD
Triamcinolone—Body temperature increased—Pravastatin—atherosclerosis	0.000419	0.00187	CcSEcCtD
Triamcinolone—Pruritus—Simvastatin—atherosclerosis	0.000415	0.00185	CcSEcCtD
Triamcinolone—Dizziness—Lovastatin—atherosclerosis	0.000414	0.00185	CcSEcCtD
Triamcinolone—Dizziness—Ezetimibe—atherosclerosis	0.000406	0.00182	CcSEcCtD
Triamcinolone—Vomiting—Lovastatin—atherosclerosis	0.000398	0.00178	CcSEcCtD
Triamcinolone—Hypersensitivity—Niacin—atherosclerosis	0.000397	0.00177	CcSEcCtD
Triamcinolone—Rash—Lovastatin—atherosclerosis	0.000395	0.00177	CcSEcCtD
Triamcinolone—Dermatitis—Lovastatin—atherosclerosis	0.000395	0.00176	CcSEcCtD
Triamcinolone—Headache—Lovastatin—atherosclerosis	0.000393	0.00175	CcSEcCtD
Triamcinolone—Vomiting—Ezetimibe—atherosclerosis	0.000391	0.00175	CcSEcCtD
Triamcinolone—Hypersensitivity—Pravastatin—atherosclerosis	0.00039	0.00174	CcSEcCtD
Triamcinolone—Dizziness—Simvastatin—atherosclerosis	0.000388	0.00173	CcSEcCtD
Triamcinolone—Rash—Ezetimibe—atherosclerosis	0.000388	0.00173	CcSEcCtD
Triamcinolone—Dermatitis—Ezetimibe—atherosclerosis	0.000387	0.00173	CcSEcCtD
Triamcinolone—Asthenia—Niacin—atherosclerosis	0.000386	0.00173	CcSEcCtD
Triamcinolone—Headache—Ezetimibe—atherosclerosis	0.000385	0.00172	CcSEcCtD
Triamcinolone—Pruritus—Niacin—atherosclerosis	0.000381	0.0017	CcSEcCtD
Triamcinolone—Asthenia—Pravastatin—atherosclerosis	0.00038	0.0017	CcSEcCtD
Triamcinolone—Pruritus—Pravastatin—atherosclerosis	0.000375	0.00168	CcSEcCtD
Triamcinolone—NR3C1—connective tissue—atherosclerosis	0.000375	0.0381	CbGeAlD
Triamcinolone—Dexamethasone—NOS2—atherosclerosis	0.000373	0.104	CrCbGaD
Triamcinolone—Vomiting—Simvastatin—atherosclerosis	0.000373	0.00167	CcSEcCtD
Triamcinolone—Nausea—Lovastatin—atherosclerosis	0.000372	0.00166	CcSEcCtD
Triamcinolone—Rash—Simvastatin—atherosclerosis	0.00037	0.00165	CcSEcCtD
Triamcinolone—Dermatitis—Simvastatin—atherosclerosis	0.000369	0.00165	CcSEcCtD
Triamcinolone—Headache—Simvastatin—atherosclerosis	0.000367	0.00164	CcSEcCtD
Triamcinolone—BCHE—cardiovascular system—atherosclerosis	0.000366	0.0373	CbGeAlD
Triamcinolone—Nausea—Ezetimibe—atherosclerosis	0.000365	0.00163	CcSEcCtD
Triamcinolone—Dizziness—Niacin—atherosclerosis	0.000356	0.00159	CcSEcCtD
Triamcinolone—Dizziness—Pravastatin—atherosclerosis	0.00035	0.00157	CcSEcCtD
Triamcinolone—Nausea—Simvastatin—atherosclerosis	0.000348	0.00156	CcSEcCtD
Triamcinolone—Vomiting—Niacin—atherosclerosis	0.000342	0.00153	CcSEcCtD
Triamcinolone—Rash—Niacin—atherosclerosis	0.000339	0.00152	CcSEcCtD
Triamcinolone—Dermatitis—Niacin—atherosclerosis	0.000339	0.00152	CcSEcCtD
Triamcinolone—Headache—Niacin—atherosclerosis	0.000337	0.00151	CcSEcCtD
Triamcinolone—Vomiting—Pravastatin—atherosclerosis	0.000337	0.00151	CcSEcCtD
Triamcinolone—Rash—Pravastatin—atherosclerosis	0.000334	0.00149	CcSEcCtD
Triamcinolone—Dermatitis—Pravastatin—atherosclerosis	0.000334	0.00149	CcSEcCtD
Triamcinolone—Headache—Pravastatin—atherosclerosis	0.000332	0.00148	CcSEcCtD
Triamcinolone—NR3C1—cardiovascular system—atherosclerosis	0.000326	0.0332	CbGeAlD
Triamcinolone—PTGS2—connective tissue—atherosclerosis	0.000324	0.033	CbGeAlD
Triamcinolone—BCHE—adipose tissue—atherosclerosis	0.000323	0.0329	CbGeAlD
Triamcinolone—Nausea—Niacin—atherosclerosis	0.00032	0.00143	CcSEcCtD
Triamcinolone—Nausea—Pravastatin—atherosclerosis	0.000315	0.00141	CcSEcCtD
Triamcinolone—NR3C1—adipose tissue—atherosclerosis	0.000288	0.0293	CbGeAlD
Triamcinolone—PTGS2—cardiovascular system—atherosclerosis	0.000282	0.0287	CbGeAlD
Triamcinolone—PTGS2—adipose tissue—atherosclerosis	0.000249	0.0253	CbGeAlD
Triamcinolone—BCHE—liver—atherosclerosis	0.000227	0.0231	CbGeAlD
Triamcinolone—NR3C1—liver—atherosclerosis	0.000202	0.0205	CbGeAlD
Triamcinolone—Betamethasone—PTGS2—atherosclerosis	0.000184	0.0513	CrCbGaD
Triamcinolone—Prednisone—ALB—atherosclerosis	0.000181	0.0506	CrCbGaD
Triamcinolone—PTGS2—liver—atherosclerosis	0.000175	0.0178	CbGeAlD
Triamcinolone—CYP3A4—liver—atherosclerosis	0.000153	0.0155	CbGeAlD
Triamcinolone—Dexamethasone—PTGS2—atherosclerosis	0.000107	0.0298	CrCbGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	8.2e-05	0.000709	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	8.15e-05	0.000705	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	8.03e-05	0.000694	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	7.95e-05	0.000687	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TGFB1—atherosclerosis	7.91e-05	0.000684	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MMP9—atherosclerosis	7.86e-05	0.00068	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PLTP—atherosclerosis	7.84e-05	0.000678	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ABCG1—atherosclerosis	7.8e-05	0.000675	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—GHRL—atherosclerosis	7.75e-05	0.00067	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—atherosclerosis	7.65e-05	0.000661	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ACE—atherosclerosis	7.51e-05	0.000649	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	7.45e-05	0.000644	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—atherosclerosis	7.39e-05	0.000639	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	7.35e-05	0.000636	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LCAT—atherosclerosis	7.34e-05	0.000634	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—FABP4—atherosclerosis	7.34e-05	0.000634	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	7.26e-05	0.000628	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	7.22e-05	0.000624	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOA4—atherosclerosis	7.2e-05	0.000623	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	7.17e-05	0.00062	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP7A1—atherosclerosis	7.07e-05	0.000612	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	7.01e-05	0.000606	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LTA4H—atherosclerosis	6.79e-05	0.000588	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCG8—atherosclerosis	6.79e-05	0.000588	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—PLAUR—atherosclerosis	6.74e-05	0.000583	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.74e-05	0.000583	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	6.71e-05	0.00058	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	6.68e-05	0.000577	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—PLG—atherosclerosis	6.59e-05	0.00057	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP27A1—atherosclerosis	6.54e-05	0.000566	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	6.48e-05	0.00056	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.44e-05	0.000557	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	6.38e-05	0.000552	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	6.34e-05	0.000548	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.28e-05	0.000543	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALOX15—atherosclerosis	6.2e-05	0.000536	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PLA2G2A—atherosclerosis	6.2e-05	0.000536	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOA2—atherosclerosis	6.2e-05	0.000536	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALOX5AP—atherosclerosis	6.2e-05	0.000536	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	6.17e-05	0.000534	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	6.14e-05	0.000531	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ABCG5—atherosclerosis	6.12e-05	0.00053	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.12e-05	0.000529	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	6.05e-05	0.000523	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF2—atherosclerosis	6e-05	0.000519	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—atherosclerosis	5.96e-05	0.000515	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOA4—atherosclerosis	5.92e-05	0.000512	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LPA—atherosclerosis	5.91e-05	0.000511	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—BGN—atherosclerosis	5.73e-05	0.000495	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.69e-05	0.000492	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOA5—atherosclerosis	5.67e-05	0.00049	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	5.65e-05	0.000488	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	5.57e-05	0.000481	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.51e-05	0.000476	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PLA2G1B—atherosclerosis	5.46e-05	0.000472	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.4e-05	0.000467	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCG1—atherosclerosis	5.37e-05	0.000464	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.35e-05	0.000462	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.33e-05	0.000461	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	5.29e-05	0.000457	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALOX5—atherosclerosis	5.27e-05	0.000456	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HSPA1B—atherosclerosis	5.23e-05	0.000453	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	5.2e-05	0.00045	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	5.15e-05	0.000445	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	5.13e-05	0.000444	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOA2—atherosclerosis	5.09e-05	0.000441	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	5.08e-05	0.000439	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	5.06e-05	0.000438	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—FABP4—atherosclerosis	5.05e-05	0.000437	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LCAT—atherosclerosis	5.05e-05	0.000437	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOA4—atherosclerosis	4.96e-05	0.000429	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	4.88e-05	0.000422	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.87e-05	0.000421	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP7A1—atherosclerosis	4.87e-05	0.000421	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MMP1—atherosclerosis	4.82e-05	0.000417	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.8e-05	0.000415	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—AGT—atherosclerosis	4.76e-05	0.000412	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NAMPT—atherosclerosis	4.73e-05	0.000409	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BGN—atherosclerosis	4.71e-05	0.000407	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.7e-05	0.000406	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LIPC—atherosclerosis	4.7e-05	0.000406	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOC3—atherosclerosis	4.67e-05	0.000404	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PARP1—atherosclerosis	4.67e-05	0.000403	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—LEP—atherosclerosis	4.66e-05	0.000403	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LDLR—atherosclerosis	4.64e-05	0.000401	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.64e-05	0.000401	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.57e-05	0.000396	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.54e-05	0.000393	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CETP—atherosclerosis	4.53e-05	0.000392	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP27A1—atherosclerosis	4.5e-05	0.000389	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.43e-05	0.000383	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ESR2—atherosclerosis	4.42e-05	0.000382	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.41e-05	0.000381	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—F2—atherosclerosis	4.4e-05	0.00038	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SCARB1—atherosclerosis	4.34e-05	0.000375	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.32e-05	0.000374	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALOX15—atherosclerosis	4.27e-05	0.000369	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PLA2G2A—atherosclerosis	4.27e-05	0.000369	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALOX5AP—atherosclerosis	4.27e-05	0.000369	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOA2—atherosclerosis	4.27e-05	0.000369	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.23e-05	0.000365	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCG5—atherosclerosis	4.21e-05	0.000364	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.21e-05	0.000364	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.11e-05	0.000356	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CST3—atherosclerosis	4.1e-05	0.000355	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HMGCR—atherosclerosis	4.1e-05	0.000354	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LPA—atherosclerosis	4.07e-05	0.000352	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—INS—atherosclerosis	3.98e-05	0.000344	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—BGN—atherosclerosis	3.94e-05	0.000341	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CCL2—atherosclerosis	3.92e-05	0.000339	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.91e-05	0.000338	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOA5—atherosclerosis	3.9e-05	0.000337	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NAMPT—atherosclerosis	3.89e-05	0.000336	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF1—atherosclerosis	3.85e-05	0.000333	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOC3—atherosclerosis	3.84e-05	0.000332	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LDLR—atherosclerosis	3.81e-05	0.00033	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.79e-05	0.000328	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PLA2G1B—atherosclerosis	3.76e-05	0.000325	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MMP2—atherosclerosis	3.73e-05	0.000322	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.71e-05	0.000321	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.7e-05	0.00032	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HSPA1B—atherosclerosis	3.68e-05	0.000319	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.68e-05	0.000318	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.67e-05	0.000318	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ABCA1—atherosclerosis	3.65e-05	0.000316	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.64e-05	0.000315	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALOX5—atherosclerosis	3.63e-05	0.000314	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NCF1—atherosclerosis	3.57e-05	0.000309	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SIRT1—atherosclerosis	3.56e-05	0.000308	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLTP—atherosclerosis	3.42e-05	0.000296	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CYBA—atherosclerosis	3.35e-05	0.00029	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.35e-05	0.00029	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PARP1—atherosclerosis	3.28e-05	0.000284	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NAMPT—atherosclerosis	3.25e-05	0.000281	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.24e-05	0.00028	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LIPC—atherosclerosis	3.23e-05	0.00028	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOC3—atherosclerosis	3.21e-05	0.000278	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LDLR—atherosclerosis	3.19e-05	0.000276	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HMOX1—atherosclerosis	3.13e-05	0.000271	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CETP—atherosclerosis	3.12e-05	0.00027	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	3.1e-05	0.000268	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.06e-05	0.000265	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOB—atherosclerosis	3e-05	0.00026	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SCARB1—atherosclerosis	2.99e-05	0.000258	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.97e-05	0.000257	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.97e-05	0.000257	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARA—atherosclerosis	2.96e-05	0.000256	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTM1—atherosclerosis	2.92e-05	0.000253	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.91e-05	0.000252	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LPL—atherosclerosis	2.87e-05	0.000248	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HMGCR—atherosclerosis	2.82e-05	0.000244	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GPX1—atherosclerosis	2.8e-05	0.000242	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CD36—atherosclerosis	2.72e-05	0.000236	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ESR1—atherosclerosis	2.68e-05	0.000232	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—MTHFR—atherosclerosis	2.58e-05	0.000223	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARA—atherosclerosis	2.53e-05	0.000219	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCA1—atherosclerosis	2.51e-05	0.000217	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOB—atherosclerosis	2.47e-05	0.000213	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AGT—atherosclerosis	2.45e-05	0.000212	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARG—atherosclerosis	2.44e-05	0.000211	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOE—atherosclerosis	2.4e-05	0.000208	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CAV1—atherosclerosis	2.38e-05	0.000206	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOA1—atherosclerosis	2.38e-05	0.000205	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LPL—atherosclerosis	2.36e-05	0.000204	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.35e-05	0.000203	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRKCG—atherosclerosis	2.29e-05	0.000198	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—FABP4—atherosclerosis	2.21e-05	0.000191	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LCAT—atherosclerosis	2.21e-05	0.000191	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	2.2e-05	0.00019	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CG—atherosclerosis	2.17e-05	0.000188	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOA4—atherosclerosis	2.16e-05	0.000187	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HMOX1—atherosclerosis	2.16e-05	0.000187	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.13e-05	0.000184	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTHFR—atherosclerosis	2.12e-05	0.000183	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARG—atherosclerosis	2.09e-05	0.000181	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOB—atherosclerosis	2.07e-05	0.000179	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFB—atherosclerosis	2.06e-05	0.000179	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—INS—atherosclerosis	2.05e-05	0.000178	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTM1—atherosclerosis	2.01e-05	0.000174	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOE—atherosclerosis	1.98e-05	0.000171	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LPL—atherosclerosis	1.97e-05	0.000171	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.97e-05	0.00017	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CAV1—atherosclerosis	1.96e-05	0.000169	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOA1—atherosclerosis	1.95e-05	0.000169	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GPX1—atherosclerosis	1.93e-05	0.000166	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALB—atherosclerosis	1.88e-05	0.000163	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CD36—atherosclerosis	1.87e-05	0.000162	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.86e-05	0.000161	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.86e-05	0.000161	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.86e-05	0.000161	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOA2—atherosclerosis	1.86e-05	0.000161	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.84e-05	0.000159	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS2—atherosclerosis	1.84e-05	0.000159	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NOS3—atherosclerosis	1.8e-05	0.000156	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LPA—atherosclerosis	1.78e-05	0.000154	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MTHFR—atherosclerosis	1.78e-05	0.000154	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARA—atherosclerosis	1.74e-05	0.000151	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—BGN—atherosclerosis	1.72e-05	0.000149	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOA5—atherosclerosis	1.7e-05	0.000147	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AGT—atherosclerosis	1.69e-05	0.000146	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—INS—atherosclerosis	1.69e-05	0.000146	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOE—atherosclerosis	1.65e-05	0.000143	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS2—atherosclerosis	1.65e-05	0.000142	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.64e-05	0.000142	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CAV1—atherosclerosis	1.64e-05	0.000142	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOA1—atherosclerosis	1.64e-05	0.000141	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.58e-05	0.000137	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SERPINE1—atherosclerosis	1.55e-05	0.000134	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.49e-05	0.000129	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS3—atherosclerosis	1.48e-05	0.000128	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARG—atherosclerosis	1.44e-05	0.000125	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MAPK3—atherosclerosis	1.43e-05	0.000124	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.42e-05	0.000123	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—INS—atherosclerosis	1.41e-05	0.000122	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LIPC—atherosclerosis	1.41e-05	0.000122	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOC3—atherosclerosis	1.4e-05	0.000121	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LDLR—atherosclerosis	1.39e-05	0.000121	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CETP—atherosclerosis	1.36e-05	0.000118	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.3e-05	0.000113	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALB—atherosclerosis	1.3e-05	0.000112	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NOS3—atherosclerosis	1.24e-05	0.000107	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.23e-05	0.000107	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.1e-05	9.5e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT3—atherosclerosis	1.06e-05	9.13e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAPK3—atherosclerosis	1.01e-05	8.72e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—atherosclerosis	9.78e-06	8.46e-05	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AKT1—atherosclerosis	9.67e-06	8.36e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HMOX1—atherosclerosis	9.42e-06	8.15e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOB—atherosclerosis	9.03e-06	7.81e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTM1—atherosclerosis	8.78e-06	7.59e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LPL—atherosclerosis	8.62e-06	7.45e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GPX1—atherosclerosis	8.41e-06	7.27e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKT1—atherosclerosis	8.28e-06	7.16e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CD36—atherosclerosis	8.19e-06	7.08e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTHFR—atherosclerosis	7.76e-06	6.71e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARA—atherosclerosis	7.61e-06	6.58e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AGT—atherosclerosis	7.37e-06	6.38e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—atherosclerosis	7.37e-06	6.38e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOE—atherosclerosis	7.22e-06	6.25e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CAV1—atherosclerosis	7.16e-06	6.19e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOA1—atherosclerosis	7.14e-06	6.18e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT1—atherosclerosis	6.8e-06	5.88e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.52e-06	5.64e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARG—atherosclerosis	6.29e-06	5.44e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—INS—atherosclerosis	6.17e-06	5.34e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKT1—atherosclerosis	5.7e-06	4.93e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALB—atherosclerosis	5.66e-06	4.89e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NOS3—atherosclerosis	5.41e-06	4.68e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.95e-06	4.28e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKT1—atherosclerosis	2.49e-06	2.15e-05	CbGpPWpGaD
